Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,977
Closed -$296K 129
2024
Q4
$296K Sell
2,977
-188
-6% -$19.4K 0.01% 81
2024
Q3
$359K Sell
3,165
-74
-2% -$8.79K 0.01% 69
2024
Q2
$401K Buy
3,239
+860
+36% +$111K 0.02% 65
2024
Q1
$310K Buy
+2,379
New +$293K 0.01% 83
2023
Q2
Sell
-3,498
Closed -$393K 113
2023
Q1
$393K Sell
3,498
-1,554
-31% -$168K 0.02% 78
2022
Q4
$561K Sell
5,052
-3,809
-43% -$389K 0.02% 56
2022
Q3
$763K Sell
8,861
-498
-5% -$44.5K 0.04% 49
2022
Q2
$853K Sell
9,359
-222
-2% -$19.7K 0.03% 55
2022
Q1
$786K Buy
9,581
+2,896
+43% +$228K 0.03% 104
2021
Q4
$512K Buy
+6,685
New +$532K 0.01% 146
2021
Q1
Sell
-1,470
Closed -$115K 329
2020
Q4
$115K Buy
+1,470
New +$112K ﹤0.01% 271

Other funds holding MRK

Krane Funds Advisors's MRK Position: Q1 2025 in Review

Krane Funds Advisors sold out of Merck (MRK) in Q1 2025, closing a stake of 2,977 shares — an estimated $296K sold.

Krane Funds Advisors first reported a position in MRK in Q4 2020 and held it in 11 quarters. The position peaked at $853K in Q2 2022. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Krane Funds Advisors reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Krane Funds Advisors sold 2,977 Merck shares in Q1 2025, an estimated $296K.
  • Krane Funds Advisors first reported a position in Merck in Q4 2020 and held it in 11 quarters.
  • Krane Funds Advisors's Merck position peaked at $853K in Q2 2022.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Krane Funds Advisors's 13F filing for Q1 2025, filed 28 Apr 2025.